Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins (Q30881660)

27 June 2017

title

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins (English)

1 reference

27 June 2017

1 reference

frontotemporal dementia

1 reference

7

Kaj Blennow

1 reference

27 June 2017

2

Magnus Sjögren

1 reference

27 June 2017

Ann Westman-Brinkmalm

6

object named as

Ann Westman-Brinkmalm

1 reference

27 June 2017

Pia Davidsson

1

1 reference

27 June 2017

Niels Andreasen

3

1 reference

27 June 2017

Maria Lindbjer

4

1 reference

27 June 2017

Carol L Nilsson

5

1 reference

27 June 2017

publication date

1 December 2002

1 reference

27 June 2017

number of pages

6

1 reference

inferred from page(s)

published in

Molecular Brain Research

1 reference

27 June 2017

volume

109

1 reference

27 June 2017

issue

1-2

1 reference

27 June 2017

page(s)

128-133

1 reference

The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Specific pathological Tau protein variants characterize Pick's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Distribution of proSAAS-derived peptides in rat neuroendocrine tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Immunodetection of protein composition in cerebral amyloid extracts in Alzheimer's disease: enrichment of retinol-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Tau Protein in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Sequence and expression analysis of bovine pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

The C-terminal Region of proSAAS Is a Potent Inhibitor of Prohormone Convertase 1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Peptide sequencing by mass spectrometry for homology searches and cloning of genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of proteins in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900549-1

7 January 2021

10.1016/S0169-328X(02)00549-1

Identifiers

DOI

1 reference

27 June 2017

1 reference